Windtree Therapeutics
WINT • NASDAQ
Windtree Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jed A. Latkin, with a market cap of $3.2M.
CEOJed A. Latkin
Next Earnings
Upcoming earnings announcement for Windtree Therapeutics
Date
Friday, May 15, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
Earnings History
Past 11 earnings reports for Windtree Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 19, 2025 | Q3 2025 | -$1.08 | — | - | — |  10-Q |
| Aug 19, 2025 | Q2 2025 | -$3.06 | — | - | — | 10-Q |
| May 16, 2025 | Q4 2024 | -$4.63 | — | - | — | — |
| Nov 27, 2024 | Q3 2024 | -$211.50 | — | - | — | 10-Q |
| Aug 19, 2024 | Q2 2024 | -$1,045.50 | — | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$462.00 | — | - | — | 10-Q |
| Apr 17, 2024 | Q4 2023 | -$855.00Est: -$846.00 | -1.1% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$774.00Est: -$567.00 | -36.5% | - | — | — |
| Aug 7, 2023 | Q2 2023 | -$1,476.00Est: -$612.00 | -141.2% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$4,284.00Est: -$504.00 | -750.0% | - | — | 10-Q |
| Apr 3, 2023 | Q4 2022 | -$11,709.00 | — | -Est: $100.0K | -100.0% | — |